A central theme in this proposal is a generic experimental design that investigates NSAID responses in five model systems, yeast, human cells, fish, mice, and man (see experimental design in the Systems Pharmacology Core). Each of these model systems offers advantages to inform NSAID responses. Because yeast don't have cyclooxygenases (COXs), but do have powerful genetics, we are using them to identify the genes and networks that regulate off target effects. We propose using human cells to understand how NSAIDs regulate cell autonomous network function in multiple cell types. Zebrafish and mice are ideal model systems for studying physiology relevant to NSAID response, e.g. how NSAIDs modify pain and blood pressure. Furthermore, they are excellent systems to find modifier genes that impact NSAID action. While zebrafish have elegant forward genetic screens, the mouse is the dominant organism for reverse genetics, and we have an array of conditional knockout mice available in this grant. Our final model system, human subjects, is the bedrock on which these studies lay. We will study NSAID response in human subjects focusing on physiological parameters such as response to pain and blood pressure. Furthermore, we will investigate individual differences in these human subjects. In all systems, we will integrate genomic information with drug levels and prostanoids and unbiased (e.g. metabolomic and lipidomic) quantitative outputs reflecting drug exposure and response. Most investigation of the physiological effects of NSAIDs has focused on the role of one or a few genes in a single model system. Here we develop a 21st-century approach that studies drug response at the network level across model systems. To do this, we need common technologies. In the Molecular Profiling Core, we propose using lipidomics, metabolomics, and proteomics to study how these small molecules are metabolized, influence prostaglandin signaling, and change the expression of proteins in a variety of experimental designs. In this core, we leverage recent advances in high throughput sequencing that now enable whole genome analysis of RNA expression dynamics, chromatin modifications, microbiome regulation, and genome sequence. This is a rapidly moving area. To ensure we stay relevant, we've enlisted Eric Schadt, Chief Scientific Officer of PacBio and Professor at UCSF, who is developing third-generation technologies to address these issues.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1-PPBC-0)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
United States
Zip Code
Martin, Sarah A; Gijón, Miguel A; Voelker, Dennis R et al. (2014) Measurement of lysophospholipid acyltransferase activities using substrate competition. J Lipid Res 55:782-91
Keramati, Ali R; Fathzadeh, Mohsen; Go, Gwang-Woong et al. (2014) A form of the metabolic syndrome associated with mutations in DYRK1B. N Engl J Med 370:1909-19
Chakraborty, Raja; Bhullar, Rajinder P; Dakshinamurti, Shyamala et al. (2014) Inverse agonism of SQ 29,548 and Ramatroban on Thromboxane A2 receptor. PLoS One 9:e85937
Zarini, Simona; Hankin, Joseph A; Murphy, Robert C et al. (2014) Lysophospholipid acyltransferases and eicosanoid biosynthesis in zebrafish myeloid cells. Prostaglandins Other Lipid Mediat 113-115:52-61
Obinata, Hideru; Gutkind, Sarah; Stitham, Jeremiah et al. (2014) Individual variation of human S1P? coding sequence leads to heterogeneity in receptor function and drug interactions. J Lipid Res 55:2665-75
Toung, Jonathan M; Lahens, Nicholas; Hogenesch, John B et al. (2014) Detection theory in identification of RNA-DNA sequence differences using RNA-sequencing. PLoS One 9:e112040
Jiang, Yan; Djuric, Zora; Sen, Ananda et al. (2014) Biomarkers for personalizing omega-3 fatty acid dosing. Cancer Prev Res (Phila) 7:1011-22
Tang, Wai Ho; Stitham, Jeremiah; Jin, Yu et al. (2014) Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets. Circulation 129:1598-609
Lu, Yi-Chien; Chang, Sung-Hee; Hafner, Markus et al. (2014) ELAVL1 modulates transcriptome-wide miRNA binding in murine macrophages. Cell Rep 9:2330-43
O'Donnell, Valerie B; Murphy, Robert C; Watson, Steve P (2014) Platelet lipidomics: modern day perspective on lipid discovery and characterization in platelets. Circ Res 114:1185-203

Showing the most recent 10 out of 19 publications